MEDIA ROOM



  • Visual inspection of by-pass syringes

    Sanofi invests €170 million in new vaccine production facility in France 

    - Expansion at Val de Reuil reinforces the company’s position as a global leader in seasonal flu vaccines -

     

    Paris, France - October 12, 2017 Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France. The expansion further strengthens Sanofi’s position as one of the world’s leading seasonal flu vaccine providers.

    - 10/12/2017